Labcorp director exercises 897 RSUs into shares

Labcorp Holdings Inc. director Peter M. Neupert reported the vesting and exercise of equity awards.

Rhea-AI Filing Summary

Labcorp Holdings Inc. director Peter M. Neupert reported the vesting and exercise of equity awards. On February 11, 2026, he exercised 897 Restricted Stock Units, converting them into 897 shares of Common Stock at an exercise price of $0 per share. Following this derivative conversion, he directly owned 13,784 shares of Common Stock and 773 Restricted Stock Units, each RSU representing the right to receive one Labcorp common share.

Insider Trade Summary

897 shares exercised/converted

Exercise 2 txns

Insider NEUPERT PETER M

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	897	$0.00	$0.00
Exercise	Common Stock	897	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 773 contracts (Direct); Common Stock — 13,784 shares (Direct)

Footnotes (3)

1. F1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
2. F2. The Restricted Stock Units vested fully on February 11, 2026.
3. F3. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Labcorp (LH) director Peter Neupert report?

Peter M. Neupert reported exercising 897 Restricted Stock Units into 897 shares of Labcorp common stock. The transaction occurred on February 11, 2026, via a derivative conversion at an exercise price of $0 per share, reflecting vesting of previously granted equity awards.

How many Labcorp (LH) common shares does Peter Neupert own after this Form 4?

After the reported transaction, Peter M. Neupert directly owns 13,784 shares of Labcorp common stock. This figure comes from the Form 4 table showing the amount of non-derivative securities beneficially owned following the February 11, 2026 derivative conversion transaction.

What happened to Peter Neupert’s Labcorp (LH) Restricted Stock Units?

897 Restricted Stock Units vested and were converted into 897 shares of Labcorp common stock. The filing notes that these RSUs fully vested on February 11, 2026, and that each Restricted Stock Unit represents the contingent right to receive one share of Labcorp common stock.

How many Restricted Stock Units does Peter Neupert still hold in Labcorp (LH)?

Following the vesting event, Peter M. Neupert holds 773 Restricted Stock Units in Labcorp. The Form 4’s derivative securities table explains that this number reflects the aggregate RSUs remaining beneficially owned after the February 11, 2026 conversion of 897 units into common shares.

What does transaction code “M” mean in Peter Neupert’s Labcorp (LH) Form 4?

Transaction code “M” indicates an exercise or conversion of a derivative security, not an open-market trade. In this case, 897 Restricted Stock Units were converted into 897 shares of Labcorp common stock as part of a scheduled vesting event on February 11, 2026.

Is Peter Neupert’s Labcorp (LH) Form 4 transaction a direct or indirect holding?

The Form 4 shows Neupert’s holdings as direct, using ownership code “D” for both the common stock and the remaining Restricted Stock Units. No footnotes indicate indirect ownership through another entity or any disclaimer of beneficial ownership in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 12:55 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

NEUPERT PETER M

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		M		897	A	(1)	13,784	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	02/11/2026		M			897	(2)	(2)	Common Stock	897	$0	773(3)	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. The Restricted Stock Units vested fully on February 11, 2026.

3. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Peter M. Neupert	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.